PD-L1 and HER2 expression in gastric cancer (GC) patients (pts) using cell-free RNA (cfRNA).

被引：3
|
作者：
Shen, James Yu Chang
Usher, Joshua
Samberg, David
Ishiba, Toshiyuki
Danenberg, Kathleen
Lenz, Heinz-Josef
Barzi, Afsaneh
机构：
[1] USC, LAC USC Med Ctr, Keck Sch Med, Los Angeles, CA USA
[2] Liquid Genom Inc, Torrance, CA USA
[3] Univ Southern Calif, Los Angeles, CA USA
[4] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e15539
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15539
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Enhancing ovarian cancer treatment by synergistically targeting HER2 and PD-L1
    Zhang, Shuo
    Pan, Qi
    Wang, Kangchun
    MOLECULAR THERAPY ONCOLOGY, 2025, 33 (01):
  • [32] Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1
    Pereira, Marina Alessandra
    Kodama Pertille Ramos, Marcus Fernando
    Dias, Andre Roncon
    Faraj, Sheila Friedrich
    Ribeiro e Ribeiro, Renan
    de Castria, Tiago Biachi
    Zilberstein, Bruno
    Ferreira Alves, Venancio Avancini
    Ribeiro Jr, Ulysses
    de Mello, Evandro Sobroza
    MOLECULAR DIAGNOSIS & THERAPY, 2019, 23 (06) : 761 - 771
  • [33] Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1
    Marina Alessandra Pereira
    Marcus Fernando Kodama Pertille Ramos
    André Roncon Dias
    Sheila Friedrich Faraj
    Renan Ribeiro e Ribeiro
    Tiago Biachi de Castria
    Bruno Zilberstein
    Venancio Avancini Ferreira Alves
    Ulysses Ribeiro
    Evandro Sobroza de Mello
    Molecular Diagnosis & Therapy, 2019, 23 : 761 - 771
  • [34] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [35] PD-L1 expression in patients with metastatic gastric cancer in South Korea
    Kim, Hyo Song
    Wu, Ting
    Kim, Hyunki
    Chung, Hyun Cheol
    Ajani, Jaffer A.
    Ku, Geoffrey Yuyat
    Kelsen, David Paul
    Zhu, Xingshu
    Savage, Mary J.
    Koshiji, Minori
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients' survival in gastric cancer
    Wang, Weili
    Liao, Ping
    He, Yijing
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (10) : 1379 - 1381
  • [37] A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients’ survival in gastric cancer
    Weili Wang
    Ping Liao
    Yijing He
    Cancer Immunology, Immunotherapy, 2017, 66 : 1379 - 1381
  • [38] Expression and Content of Protein LC3B in Gastric Cancer Tissue, Relationship with Expression of mTOR, AMPK in Gastric Cancer Tissue and HER2 and PD-L1 Status of the Tumor
    L. V. Spirina
    A. V. Avgustinovich
    S. G. Afanas’ev
    M. Yu. Volkov
    I. V. Kondakova
    Bulletin of Experimental Biology and Medicine, 2021, 172 : 202 - 205
  • [39] Expression and Content of Protein LC3B in Gastric Cancer Tissue, Relationship with Expression of mTOR, AMPK in Gastric Cancer Tissue and HER2 and PD-L1 Status of the Tumor
    Spirina, L., V
    Avgustinovich, A., V
    Afanas'ev, S. G.
    Volkov, M. Yu
    Kondakova, I., V
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 172 (02) : 202 - 205
  • [40] Elevated PD-L1 and HER2 expression on aneuploid carcinoma cells in malignant ascites accelerate stumor cell immune evasion in gastrointestinal cancer patients
    Chen, Yang
    Qi, Changsong
    Yuan, JiaJia
    Liu, Dan
    Peng, Zhi
    Zhang, Xiaotian
    Li, Jian
    Lin, Pin Peter
    Li, Yilin
    Shen, Lin
    CANCER RESEARCH, 2020, 80 (16)
12345